Literature DB >> 23577624

Dissemination of aminoglycoside-modifying enzymes and 16S rRNA methylases among acinetobacter baumannii and Pseudomonas aeruginosa isolates.

Mohammad Aghazadeh1, Mohammad Ahangarzadeh Rezaee, Mohammad Reza Nahaei, Reza Mahdian, Omid Pajand, Fereshteh Saffari, Maryam Hassan, Zoya Hojabri.   

Abstract

AIMS: The purpose of the present study was to investigate the diversity of the genes encoding aminoglycoside-modifying enzymes (AMEs) and their associations with resistance phenotypes and clonality in Acinetobacter baumannii and Pseudomonas aeruginosa isolates.
METHODS: Seventy six P. aeruginosa and 75 A. baumannii isolates were collected from three University affiliated hospitals in Tehran. MIC determination of amikacin and gentamicin as well as the disk diffusion method for tobramycin, netilmicin, and kanamycin were carried out. Nine AMEs genes and three RNA methylases were investigated in all isolates using the PCR method. Clonality for A. baumannii and P. aeruginosa was investigated using repetitive extragenic palindromic and enterobacterial repetitive intergenic consensus PCR, respectively.
RESULTS: aph(3')-VIa (90.6%) and aph(3')-IIb (61.8%) were the most prevalent AME genes in A. baumannii and P. aeruginosa, respectively. Eight (26%) amikacin highly resistant A. baumannii isolates were positive for armA methylase. Phenotypes and clonality did not link to the genetic determinants of resistance to aminoglycosides in our isolates.
CONCLUSIONS: AMEs genes are disseminated in different clones of A. baumannii and P. aeruginosa isolates in Iran. Other than AMEs, there are more complex and multifactorial mechanisms that result in aminoglycoside-resistant phenotypes.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23577624     DOI: 10.1089/mdr.2012.0223

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  15 in total

1.  Synthesis and antibacterial activity of 4″ or 6″-alkanoylamino derivatives of arbekacin.

Authors:  Kazushige Sasaki; Yoshihiko Kobayashi; Takashi Kurihara; Yohei Yamashita; Yoshiaki Takahashi; Toshiaki Miyake; Yuzuru Akamatsu
Journal:  J Antibiot (Tokyo)       Date:  2015-05-20       Impact factor: 2.649

2.  Molecular Epidemiology of Emerging blaOXA-23-Like- and blaOXA-24-Like-Carrying Acinetobacter baumannii in Taiwan.

Authors:  Shu-Chen Kuo; Wei-Cheng Huang; Tzu-Wen Huang; Hui-Ying Wang; Jui-Fen Lai; Te-Li Chen; Tsai-Ling Lauderdale
Journal:  Antimicrob Agents Chemother       Date:  2018-02-23       Impact factor: 5.191

3.  Imipenem/Relebactam Resistance in Clinical Isolates of Extensively Drug Resistant Pseudomonas aeruginosa: Inhibitor-Resistant β-Lactamases and Their Increasing Importance.

Authors:  Andrea M Hujer; Christopher R Bethel; Magdalena A Taracila; Steven H Marshall; Laura J Rojas; Marisa L Winkler; Ronald E Painter; T Nicholas Domitrovic; Richard R Watkins; Ayman M Abdelhamed; Roshan D'Souza; Andrew R Mack; Richard C White; Thomas Clarke; Derrick E Fouts; Michael R Jacobs; Katherine Young; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2022-04-18       Impact factor: 5.938

4.  Antibiotic Resistance in Pseudomonas.

Authors:  Pablo Laborda; Sara Hernando-Amado; José Luis Martínez; Fernando Sanz-García
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

5.  Clonal Dissemination of Clinical Isolates of Acinetobacter baumannii Carriers of 16S rRNA Methylase Genes in an Oncological Hospital in Recife, Brazil.

Authors:  Jussyêgles Niedja da Paz Pereira; Carlos Alberto das Neves de Andrade; Jailton Lobo da Costa Lima; Reginaldo Gonçalves de Lima Neto; Paulo Sérgio Ramos de Araújo; Maria Amélia Vieira Maciel
Journal:  Curr Microbiol       Date:  2019-10-26       Impact factor: 2.188

6.  Antimicrobial resistance determinants in Acinetobacter baumannii isolates taken from military treatment facilities.

Authors:  Chris Rowe Taitt; Tomasz A Leski; Michael G Stockelman; David W Craft; Daniel V Zurawski; Benjamin C Kirkup; Gary J Vora
Journal:  Antimicrob Agents Chemother       Date:  2013-11-18       Impact factor: 5.191

7.  Antibiotic Resistance of Acinetobacter baumannii in Iran: A Systemic Review of the Published Literature.

Authors:  Jale Moradi; Farhad B Hashemi; Abbas Bahador
Journal:  Osong Public Health Res Perspect       Date:  2015-02-19

8.  Combination Therapy of Sophoraflavanone B against MRSA: In Vitro Synergy Testing.

Authors:  Su-Hyun Mun; Ok-Hwa Kang; Dae-Ki Joung; Sung-Bae Kim; Yun-Soo Seo; Jang-Gi Choi; Young-Seob Lee; Seon-Woo Cha; Young-Sup Ahn; Sin-Hee Han; Dong-Yeul Kwon
Journal:  Evid Based Complement Alternat Med       Date:  2013-11-10       Impact factor: 2.629

9.  Molecular survey of aminoglycoside-resistant Acinetobacter baumannii isolated from tertiary hospitals in Qazvin, Iran.

Authors:  P Rashvand; A Peymani; M Mohammadi; A A Karami; R Samimi; S Hajian; D Porasgari; N Habibollah-Pourzereshki
Journal:  New Microbes New Infect       Date:  2021-04-23

Review 10.  Antibiotic Resistance Profiles, Molecular Mechanisms and Innovative Treatment Strategies of Acinetobacter baumannii.

Authors:  Corneliu Ovidiu Vrancianu; Irina Gheorghe; Ilda Barbu Czobor; Mariana Carmen Chifiriuc
Journal:  Microorganisms       Date:  2020-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.